Category: Forbes

Science May Have Just Uncovered Why Binge Drinking Is So Seductive For Many, And That Could Be Big

New research shows for the first time why some people may be more prone to alcohol binging than others, and the implications for alcohol abuse treatment could be huge.

Amgen Announces Major Price Cut For Its Breakthrough Cholesterol Drug

The price cut is a market-based approach that is much more likely to succeed in lowering drug prices while allowing investments in research for new innovative therapies to continue.

In Unprecedented Move, Amgen Cuts Price Of Cholesterol Drug Repatha By 60%

“We’ve got to make sure those who need [Repatha] can get it,” says Robert Bradway, Amgen’s chairman and chief executive. “The losers are the patients who have gone to the pharmacy counter and have not been able to get the medicine they need.”

Do IBM Watson Health’s Leadership Change And Layoffs Mean A.I. Is Bad Medicine?

IBM has had to shake up its Watson Health division after failing to sell its Oncology product to many hospitals. How is this instructive about the use of AI in Medicine?

As Employers Successfully Lower Health Costs, Senators Are Listening

The Senate Committee on Health Education Labor and Pensions recently held a hearing on the hot button topic of health care transparency. Increasing transparency is a bipartisan issue and requires participation from both employers and policymakers.

$289M Monsanto Weedkiller Verdict Cut To $78M, Taxes Still High

The $289M Roundup verdict against Monsanto was cut to $78M, but the plaintiff still faces tough tax rules that make him pay tax on his legal fees.

Centene Rolls Out RxAdvance PBM Promising Drug Cost Transparency

Centene has begun rolling out its new relationship with the pharmacy benefit manager, RxAdvance, a cloud-based PBM.

FDA Experts May Reconsider Diabetes Drug Safety Rules

Today and tomorrow, the FDA is convening a panel of experts to give it advice on what kind of studies it should require to determine whether diabetes drugs help the heart, or hurt it.

Amazon And NIH To Link Biomedical Data And Researchers

There is immense potential here to advance human health by driving new discoveries that enable more accurate disease risk prediction, tailored diagnostics and prevention and treatment strategies.

How To Protect Healthcare IoT Devices In A Zero Trust World

18% of healthcare employees are willing to sell confidential data to unauthorized parties for as little as $500 to $1,000, and 24% of employees know of someone who has sold privileged credentials to outsiders, according to a recent Accenture survey.